1994
DOI: 10.1007/bf01954498
|View full text |Cite
|
Sign up to set email alerts
|

High-dose intravenous immunoglobulin treatment in cryptogenic West and Lennox-Gastaut syndrome; an add-on study

Abstract: In an add-on pilot study, a group of 15 children with cryptogenic and intractable West syndrome (3) and Lennox-Gastaut syndrome (12) received intravenous immunoglobulin (IVIg, 0.4 g/kg body weight per day for 5 consecutive days, followed by the same dose once every 2 weeks for 3 months). Five patients had been treated previously with ACTH without success. The reduction in clinical seizures averaged 70%. Electroencephalographic (EEG) recordings revealed a mean reduction in epileptic discharges of 40%. In all 15… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
30
0
1

Year Published

1996
1996
2019
2019

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 55 publications
(31 citation statements)
references
References 27 publications
0
30
0
1
Order By: Relevance
“…For many years, VPA and benzodiazepines were frequently the mainstays of therapy (28). FBM, vigabatrin, and intravenous immunoglobulin have demonstrated efficacy in controlling seizures in LGS patients (29)(30)(31)(32)(33). Unfortunately, FBM use is limited by its reported association with aplastic anemia and hepatotoxicity, vigabatrin is still an investigational AED in the United States, and long-term intravenous immunoglobulin use in LGS children frequently involves technical problems with intravenous access, at times requiring placement of an indwelling catheter.…”
Section: Discussionmentioning
confidence: 99%
“…For many years, VPA and benzodiazepines were frequently the mainstays of therapy (28). FBM, vigabatrin, and intravenous immunoglobulin have demonstrated efficacy in controlling seizures in LGS patients (29)(30)(31)(32)(33). Unfortunately, FBM use is limited by its reported association with aplastic anemia and hepatotoxicity, vigabatrin is still an investigational AED in the United States, and long-term intravenous immunoglobulin use in LGS children frequently involves technical problems with intravenous access, at times requiring placement of an indwelling catheter.…”
Section: Discussionmentioning
confidence: 99%
“…The available data regarding a benefit for IGIV treatment comes mostly from uncontrolled open series or case reports. [194][195][196][197] However, there are 2 randomized placebo-controlled trials that have been performed for Lennox-Gastaut syndrome. One was a small (n 5 10) single-blind crossover study.…”
Section: Multiple Sclerosismentioning
confidence: 99%
“…Foi observada significativa redução das crises em crianças que usavam imunoglobulina endovenosa para tratamento de patologias respiratórias e passaram a usá-la como tratamento dos EI 13 . Neste estudo foi utilizada a dose de 400 mg/kg/dia, durante 5 dias e repetido a cada 2 semanas por 3 meses, com resultados esperançosos.…”
Section: Discussionunclassified